PINNA, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 53.244
NA - Nord America 1.982
AS - Asia 260
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 55.494
Nazione #
IT - Italia 52.754
US - Stati Uniti d'America 1.973
CN - Cina 187
UA - Ucraina 172
SE - Svezia 120
DE - Germania 59
GB - Regno Unito 54
FI - Finlandia 41
VN - Vietnam 22
SG - Singapore 21
BE - Belgio 13
FR - Francia 13
KR - Corea 10
CA - Canada 9
IL - Israele 7
IN - India 5
ES - Italia 4
HK - Hong Kong 4
RU - Federazione Russa 4
BR - Brasile 3
EU - Europa 3
NL - Olanda 3
PL - Polonia 3
CH - Svizzera 2
TH - Thailandia 2
CL - Cile 1
HR - Croazia 1
JP - Giappone 1
LB - Libano 1
MU - Mauritius 1
PT - Portogallo 1
Totale 55.494
Città #
Cagliari 52.632
Fairfield 250
Chandler 238
Woodbridge 237
Ann Arbor 150
Ashburn 146
Wilmington 112
Seattle 111
Houston 96
Nyköping 96
Cambridge 91
Jacksonville 81
Dearborn 71
New York 54
Shanghai 39
Nanjing 37
Beijing 32
Boardman 26
Boston 26
Dong Ket 22
Helsinki 15
San Diego 14
Brussels 13
Nanchang 10
Rome 10
Sassari 10
Seoul 10
Shenyang 10
Falls Church 9
Hebei 9
Singapore 8
Toronto 8
Los Angeles 7
Milan 7
Redwood City 7
Beersheba 6
Chicago 6
Jiaxing 6
Mountain View 6
Oristano 6
Padova 6
Jinan 5
Kunming 5
London 5
Norwalk 5
Pune 5
Grottammare 4
Hong Kong 4
Sestu 4
Tianjin 4
Washington 4
Zhengzhou 4
Cracow 3
Essen 3
Florence 3
Hangzhou 3
Hefei 3
Kilburn 3
Monopoli 3
Orange 3
Prescot 3
Atlanta 2
Auburn Hills 2
Baltimore 2
Bangkok 2
Bolzano 2
Chengdu 2
Gonnosfanadiga 2
Guangzhou 2
Indiana 2
Madrid 2
Monza 2
Nuoro 2
Verona 2
Xian 2
Aci Catena 1
Acton 1
Ashdod 1
Baotou 1
Baratili San Pietro 1
Bay Springs 1
Borås 1
Changsha 1
Chiswick 1
Dübendorf 1
Fuzhou 1
Genoa 1
Genova 1
Gunzenhausen 1
Hounslow 1
Lanzhou 1
Montreal 1
Ningbo 1
Phoenix 1
Pieve D'alpago 1
Potenza 1
Quzhou 1
Redmond 1
Saint Albans 1
San Mateo 1
Totale 54.859
Nome #
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.382
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 2.977
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.689
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 2.626
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia 2.495
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2.476
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.425
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 2.363
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease 2.326
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.295
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging 2.084
Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age 2.065
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.053
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A2A receptor antagonists 2.049
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 1.877
null 1.651
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.606
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 1.604
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration 1.577
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.553
Antiparkinsonian actions and interactions of adenosine antagonists 1.438
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.412
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats 1.041
null 1.012
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions 990
null 967
Adenosine A2A receptor antagonist treatment of Parkinson’s disease 957
null 801
Fos expression induced by olanzapine and risperidone in the central extended amygdala 705
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 613
null 410
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 405
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease 316
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 313
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 119
Totale 55.672
Categoria #
all - tutte 63.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019204 0 0 0 0 0 0 0 0 0 0 0 204
2019/202012.845 573 408 95 140 5.153 3.308 1.720 315 234 321 188 390
2020/202115.804 484 586 697 5.147 3.419 1.543 1.062 739 290 790 614 433
2021/20223.056 317 232 151 142 220 225 284 189 218 351 323 404
2022/20234.735 455 676 566 405 420 425 236 285 314 333 414 206
2023/20243.780 199 201 148 258 399 665 659 300 172 282 339 158
Totale 55.672